基于前置审方数据的药师干预对肝功能异常患者医生处方行为的影响  

Effect of Pharmacist Intervention on the Changes of Doctors'Prescribing Behavior in Patients with Abnormal Liver Function Based on Pre-examination Data

作　　者：陈钦榜 田洁[1] 吴建龙[1] CHEN Qinbang;TIAN Jie;WU Jianlong(Shenzhen Second People’s Hospital,The First Affiliated Hospital of Shenzhen University,Guangdong Shenzhen 518035)

机构地区：[1]深圳市第二人民医院深圳大学附属第一医院,广东深圳518035

出　　处：《深圳中西医结合杂志》2024年第6期80-83,共4页Shenzhen Journal of Integrated Traditional Chinese and Western Medicine

基　　金：深圳市医学重点学科经费资助项目(SZXK060)。

摘　　要：目的:分析前置审方系统用药警示下药师干预对住院患者肝功能异常下医生处方行为改变的影响。方法:选取深圳市第二人民医院2019年1月至12月前置审方的用药临床决策支持系统(CDSS)发出用药警示的67例肝功能异常住院患者的医嘱数据,根据是否进行药师干预(药师在CDSS用药警示下提醒医生调整医嘱)分为药师干预组26例和药师未干预组41例,比较两组医生处方行为改变情况。结果:CDSS对67例肝功能异常患者发出98次用药警示。CDSS对肝功能异常患者发出用药警示所涉及药物共11种,其中帕瑞昔布注射剂、艾司奥美拉唑注射剂警示次数占比最多,分别为25.51%、22.45%。药师干预组医生处方行为接受修改率为65.39%,高于药师未干预组的34.15%,差异具有统计学意义(P<0.05)。结论:前置审方系统用药警示下药师干预对肝功能异常下医生处方行为改变有明显促进作用。Objective To analyze the effect of pharmacists'intervention on the changes of doctors'prescribing behavior in inpatients with abnormal liver function under pre-examination drug warning system.Methods The medical order data of 67 inpatients with abnormal liver function who were issued pre-examination drug warnings by the drug clinical decision support system(CDSS)of Shenzhen Second People's Hospital from January to December 2019 were selected.According to whether or not pharmacists intervened(pharmacists reminded doctors to adjust medical orders under the CDSS drug warning),26 cases were divided into the pharmacists intervention group and 41 cases were divided into the pharmacists non-intervention group.The changes in prescribing behavior were compared between the two groups.Results CDSS issued 98 drug warnings to 67 patients with abnormal liver function.There were 11 kinds of drugs involved in CDSS warning for patients with abnormal liver function,among which Parecoxib injection and esomeprazole injection accounted for the most,25.51%and 22.45%respectively.The modification rate of doctors'prescription behavior in the pharmacist intervention group was 65.39%,which was higher than that in the pharmacist nonintervention group(34.15%),and the difference was statistically significant(P<0.05).Conclusion Pharmacists'intervention with pre-examination drug warning system can significantly promote the change of doctors'prescribing behavior in patients with abnormal liver function.

关 键 词：肝功能异常 用药临床决策支持系统 前置审方 药师干预 

分 类 号：R952[医药卫生—药学]